As Sanofi's Pompe drug shortage drags on, some patients struggle to access treatments
An ongoing shortage of Sanofi’s Pompe disease treatment is forcing some patients to miss critical doses. They worry their health is at risk.
We haven't written up this one. CNBC has the full story — the link below goes straight to it.